SCHEMBL7222886

SCHEMBL7222886

S=C(NCc1ccccc1)N1CCCC1

nearest known ligand 0.97

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.71
▸ MEN1 O00255 5/20 0.71
▸ POLB P06746 3/20 0.71
▸ HTT P42858 4/20 0.69
▸ SMN1; SMN2 Q16637 2/20 0.69
▸ NPC1 O15118 1/20 0.69
▸ RAB9A P51151 1/20 0.69
▸ ALDH1A1 P00352 7/20 0.68
▸ GAA P10253 4/20 0.68
▸ LMNA P02545 3/20 0.68
▸ MAPT P10636 4/20 0.64
▸ TDP1 Q9NUW8 1/20 0.63
▸ KDM4E B2RXH2 1/20 0.57
▸ PKM P14618 2/20 0.56
▸ HPGD P15428 1/20 0.55
▸ ALOX12 P18054 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7762106 0.83 NPC1 (0.97) KMT2AMEN1POLBHTTSMN1; SMN2
SCHEMBL5370512 0.80 KMT2A (0.59) KMT2AMEN1POLBHTTSMN1; SMN2
SCHEMBL23951675 0.79 KMT2A (0.67) KMT2AMEN1POLBHTTSMN1; SMN2
SCHEMBL4197501 0.79 KDM4E (0.69) KMT2AMEN1HTTSMN1; SMN2ALDH1A1
SCHEMBL5370503 0.78 ALDH1A1 (0.77) KMT2AMEN1POLBSMN1; SMN2ALDH1A1
SCHEMBL5217325 0.77 KDM4E (0.68) KMT2AMEN1HTTSMN1; SMN2ALDH1A1
SCHEMBL6559744 0.77 KDM4E (0.68) KMT2AMEN1HTTSMN1; SMN2ALDH1A1
SCHEMBL23951454 0.77 NPC1 (0.47) KMT2AMEN1POLBHTTSMN1; SMN2
SCHEMBL23951678 0.77 GAA (0.85) KMT2AMEN1POLBHTTSMN1; SMN2
SCHEMBL29350885 0.76 DPP4 (0.57) KMT2AMEN1POLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531612-B2 Pyrrolidine-2-carboxylic acid cyano-methyl amide derivatives useful for treating diseases associated with cystein proteases, such as osteoporosis, osteoarthritis, rheumatoid arthritis, tumor metastasis, glomerulonephritis HOFFMAN-LA ROCHE INC. 2003-03-11 — — US disclosed
Send feedback